OXiGENE is conducting multiple clinical trials in oncology. To learn about enrollment criteria and who to contact for further information about each trial, please click on the links provided. If you think that you meet the criteria shown, please contact the appropriate study coordinator for further information. Other than by participating in a clinical trial, patients cannot receive ZYBRESTAT (fosbretabulin) or other OXiGENE investigational compounds.